These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 11994763

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization.
    Li WW, Casey R, Gonzalez EM, Folkman J.
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2898-905. PubMed ID: 1917393
    [Abstract] [Full Text] [Related]

  • 3. (2-Hydroxypropyl)-β-Cyclodextrin Is a New Angiogenic Molecule for Therapeutic Angiogenesis.
    Qi X, Yuan Y, Xu K, Zhong H, Zhang Z, Zhai H, Guan G, Yu G.
    PLoS One; 2015 Oct; 10(5):e0125323. PubMed ID: 25944736
    [Abstract] [Full Text] [Related]

  • 4. Control of angiogenesis with synthetic heparin substitutes.
    Folkman J, Weisz PB, Joullié MM, Li WW, Ewing WR.
    Science; 1989 Mar 17; 243(4897):1490-3. PubMed ID: 2467380
    [Abstract] [Full Text] [Related]

  • 5. The angiogenesis inhibitor beta-cyclodextrin tetradecasulfate inhibits ecto-protein kinase activity.
    Skubitz KM, Ehresmann DD.
    Cell Mol Biol; 1992 Sep 17; 38(6):543-60. PubMed ID: 1284648
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of angiostatic steroids and beta-cyclodextrin tetradecasulfate on corneal neovascularization in the rat.
    Proia AD, Hirakata A, McInnes JS, Scroggs MW, Parikh I.
    Exp Eye Res; 1993 Dec 17; 57(6):693-8. PubMed ID: 7512045
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of angiostatic steroids and dexamethasone on angiogenesis and cytokine levels in rat sponge implants.
    Hori Y, Hu DE, Yasui K, Smither RL, Gresham GA, Fan TP.
    Br J Pharmacol; 1996 Aug 17; 118(7):1584-91. PubMed ID: 8842418
    [Abstract] [Full Text] [Related]

  • 11. The effects of cyclodextrins on the disposition of intravenously injected drugs in the rat.
    Frijlink HW, Franssen EJ, Eissens AC, Oosting R, Lerk CF, Meijer DK.
    Pharm Res; 1991 Mar 17; 8(3):380-4. PubMed ID: 2052529
    [Abstract] [Full Text] [Related]

  • 12. Cultivated Orostachys japonicus extract inhibits VEGF-induced angiogenesis via regulation of VEGFR2 signaling pathway in vitro and in vivo.
    Cho HD, Lee KW, Won YS, Kim JH, Seo KI.
    J Ethnopharmacol; 2020 Jun 28; 256():112664. PubMed ID: 32045685
    [Abstract] [Full Text] [Related]

  • 13. Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles.
    Pitha J, Gerloczy A, Olivi A.
    J Pharm Sci; 1994 Jun 28; 83(6):833-7. PubMed ID: 9120816
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological regulation of platelet factors that influence tumor angiogenesis.
    Yan M, Lesyk G, Radziwon-Balicka A, Jurasz P.
    Semin Oncol; 2014 Jun 28; 41(3):370-7. PubMed ID: 25023352
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beta-cyclodextrins enhance bioavailability of pilocarpine.
    Freedman KA, Klein JW, Crosson CE.
    Curr Eye Res; 1993 Jul 28; 12(7):641-7. PubMed ID: 8222723
    [Abstract] [Full Text] [Related]

  • 17. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease.
    Teicher BA, Sotomayor EA, Huang ZD.
    Cancer Res; 1992 Dec 01; 52(23):6702-4. PubMed ID: 1384969
    [Abstract] [Full Text] [Related]

  • 18. [Inhibition of pulmonary metastases in mice by beta-cyclodextrin-benzaldehyde].
    Masuyama K, Ochiai H, Ishizawa S, Yamashita I, Matsui H, Tazawa K, Niwayama S, Fujimaki M.
    Gan To Kagaku Ryoho; 1988 Mar 01; 15(3):443-7. PubMed ID: 3348630
    [Abstract] [Full Text] [Related]

  • 19. Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis.
    Lin CJ, Lin YL, Luh F, Yen Y, Chen RM.
    Oncotarget; 2016 Jul 05; 7(27):42408-42421. PubMed ID: 27285755
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.